title: Congenital anomalies after prenatal ecstasy exposure.
abstract: Prospective follow-up of 136 babies exposed to ecstasy in utero indicated that the drug may be associated with a significantly increased risk of congenital defects (15.4% [95% CI 8.2-25.4]). Cardiovascular anomalies (26 per 1000 livebirths [3.0-90.0]) and musculoskeletal anomalies (38 per 1000 [8.0-109.0]) were predominant.
authors.forename: P R
authors.initials: PR
authors.lastname: McElhatton
authors.forename: D N
authors.initials: DN
authors.lastname: Bateman
authors.forename: C
authors.initials: C
authors.lastname: Evans
authors.forename: K R
authors.initials: KR
authors.lastname: Pughe
authors.forename: S H
authors.initials: SH
authors.lastname: Thomas
mesh_terms: D000014:Abnormalities, Drug-Induced / Q000453:epidemiology* / Q000209:etiology; D000293:Adolescent; D000328:Adult; D005260:Female; D006213:Hallucinogens / Q000009:adverse effects*; D006801:Humans; D007231:Infant, Newborn; D008297:Male; D018817:N-Methyl-3,4-methylenedioxyamphetamine / Q000009:adverse effects*; D011247:Pregnancy; D011446:Prospective Studies
chemical_list: D006213:Hallucinogens; D018817:N-Methyl-3,4-methylenedioxyamphetamine